Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2032

Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
OTHER

Circulating tumor DNA treatment monitoring

A comparison of treatment monitoring by circulating tumor DNA and CT scans (standard) in patients with newly diagnosed advanced Non-Small Cell Lung Cancer (NSCLC)

Trial Locations (4)

Unknown

RECRUITING

Department of Clinical Oncology, Hillerød

RECRUITING

Department of Clinical Oncology and Palliative Care, Næstved

NOT_YET_RECRUITING

Department of Oncology, Aalborg

NOT_YET_RECRUITING

Department of Oncology, Vejle

All Listed Sponsors
lead

Zealand University Hospital

OTHER